32
Participants
Start Date
February 29, 2004
Primary Completion Date
December 31, 2010
Study Completion Date
July 31, 2013
Bort, Dex, and Dox with ALCAR
Bortezomib 1.3 mg/m2 IV days 1, 4, 8, and 11 Dexamethasone 20 mg PO days 1, 4, 8, and 11 Doxorubicin 15 mg/m2 IV days 1 and 8 Acetyl-L-Carnitine (ALCAR) 1.5 g PO BID days 1-21 Maximum of 8 cycles. Each cycle is 21 days long
University of Wisconsin Cancer Center, Madison
Mercy Health Systems, Janesville
Gundersen Lutheran, La Crosse
Regional Cancer Center, Waukesha/Oconomowoc
Aspirus Wausau Hospital, Aspirus Regional Cancer Center, Wausau
Collaborators (1)
Millennium Pharmaceuticals, Inc.
INDUSTRY
University of Wisconsin, Madison
OTHER